Abstract
Background Ablation strategies for patients with symptomatic atrial fibrillation (AF) and isolated pulmonary veins (PV) vary and their impact on arrhythmia recurrence remains unclear. This prospective randomized German multi—center trial sought to compare two ablation strategies in this patient cohort.
Methods Patients with AF despite durable PV isolation were randomly assigned at seven centers to undergo low-voltage area (LVA) ablation using 3D mapping and irrigated radiofrequency current ablation (group A) or empirical left atrial appendage isolation (LAAI) utilizing the cryoballoon (CB) followed by staged interventional LAA closure (group B). The primary endpoint was freedom from atrial tachyarrhythmias between 91 and 365 days after index ablation. The study was powered for superiority of LAAI compared to LVA.
Results Patients (40% female, mean age 68.8±8 years) with paroxysmal (32%) or persistent AF (68%) were randomized to undergo LVA ablation (n=79) or CB guided LAAI (n=82). After a planned interim analysis enrollment was halted on January 10th 2023.
In the LAAI group 77/82 LAAs were successfully isolated with subsequent LAAC in 57 patients. Procedure related complications occurred in 4 (5%) and 11 (13.5%) patients in group A and B, respectively (P=0.10). The median follow-up was 367 (IQR 359-378) days. The Kaplan Meier point estimate for the freedom from a primary endpoint event was 51.7% (CI 40.9-65.4%) for group A and 55.5% (CI 44.4-69.2%; p=0.8069).
Conclusions The present study did not detect superiority of CB guided LAAI over LVA ablation in patients with AF despite durable PVI.
It was registered at https://clinicaltrials.gov/study/NCT04056390
What is new?
This is the first randomized multi-center study to compare two different ablation strategies in AF patients with durable PVI.
Empirical LAAI was not associated with better outcome in comparison to low-voltage area ablation.
What are the clinical implications?
LAAI should not be advocated as a stand-alone ablation strategy for patients with AF recurrences after prior ablation.
The patient with AF recurrence after prior catheter ablation should be informed that if all PVs are found durably isolated the optimal ablation strategy remains uncertain.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
https://clinicaltrials.gov/study/NCT04056390
Funding Statement
The trial was supported by an unrestricted educational research grant of Medtronic.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The trial was approved by the ethics committee of the Landesaerztekammer Hessen (2023-3251-evBO) and complies with the declaration of Helsinki.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Twitter Handle: LAA Isolation does not top low-voltage ablation in patients with durable PVI.
Data Availability
Data can be accessed with permission of the author